Navigation Links
SEIU Statement in Support of New Blueprint to Solve Health Care Crisis by Senator Max Baucus
Date:11/12/2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5FDA Launches Orphan Drug Workshop at KGI 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Researchers prolong the plasma half life of biopharmaceutical proteins 14192 1Researchers prolong the plasma half life of biopharmaceutical proteins 14192 2Pivotal Registration Trial of OPAXIO Maintenance Therapy in First Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients Cell Therapeutics 5026 1Pivotal Registration Trial of OPAXIO Maintenance Therapy in First Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients Cell Therapeutics 5026 2Pivotal Registration Trial of OPAXIO Maintenance Therapy in First Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients Cell Therapeutics 5026 3Pivotal Registration Trial of OPAXIO Maintenance Therapy in First Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients Cell Therapeutics 5026 4Fortebio Inc to Present at UBS Global Life Sciences Conference 14190 1